General Information of Drug (ID: DMU8KOD)

Drug Name
Anakinra Drug Info
Synonyms Kineret; Kineret (TN); Anakinra (USAN/INN)
Indication
Disease Entry ICD 11 Status REF
Rheumatoid arthritis FA20 Approved [1]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 3 [2]
CINCA syndrome Investigative [3]
Therapeutic Class
Antiinflammatory Agents
Cross-matching ID
TTD Drug ID
DMU8KOD

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Discontinued Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
SB 203580 DMAET6F N. A. N. A. Terminated [6]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin 1 receptor type 1 (IL1R1) TTWOTEA IL1R1_HUMAN Antagonist [4]
HUMAN interleukin-1 receptor 1 (IL1R1) TTT7FOP IL1R1_HUMAN Antagonist [5]

References

1 FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (BLA) 103950.
2 ClinicalTrials.gov (NCT04364009) Anakinra for COVID-19 Respiratory Symptoms. U.S. National Institutes of Health.
3 Clinical and genetic characterization of Italian patients affected by CINCA syndrome. Rheumatology (Oxford). 2007 Mar;46(3):473-8.
4 IL-1 receptor antagonism and muscle gene expression in patients with type 2 diabetes. Eur Cytokine Netw. 2009 Jun 1;20(2):81-87.
5 FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (BLA) 125166.
6 IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. J Cell Physiol. 2001 Jun;187(3):294-303.